Αρχειοθήκη ιστολογίου

Δευτέρα 17 Δεκεμβρίου 2018

Being Explicit About Decisions: Prescribe Medications for Opioid Use Disorder on the Basis of Proven Effectiveness, Not Beliefs

Murphy and colleagues report a cost-effectiveness analysis of sublingual buprenorphine with naloxone versus extended-release naltrexone to treat opioid use disorder. The editorialists believe the analysis is an eloquent demonstration of how cost-effectiveness analysis forces us to be explicit about the factors that influence our decisions.

from A via a.sfakia on Inoreader https://ift.tt/2Llbuvc

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader